JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masubuchi, Y.
Right arrow Articles by Horie, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masubuchi, Y.
Right arrow Articles by Horie, T.

Vol. 292, Issue 3, 982-987, March 2000

Possible Mechanism of Hepatocyte Injury Induced by Diphenylamine and Its Structurally Related Nonsteroidal Anti-Inflammatory Drugs

Yasuhiro Masubuchi, Shoko Yamada and Toshiharu Horie

Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan

Diphenylamine is a common structure of nonsteroidal anti-inflammatory drugs (NSAIDs) to uncouple mitochondrial oxidative phosphorylation and to cause a decrease in hepatocellular ATP content and hepatocyte injury. The mechanism for acute cell injury induced by diphenylamine and its structurally related NSAIDs was investigated with rat liver mitochondria and freshly isolated hepatocytes, focusing on the relation to the uncoupling of oxidative phosphorylation. Incubation of mitochondria with diphenylamine as well as mefenamic acid and diclofenac caused pseudoenergetic mitochondrial swelling, indicating that these compounds induce mitochondrial membrane permeability transition. Diphenylamine also caused changes in safranine-binding spectra to mitochondria that was energized by succinate oxidation. This spectral shift indicates the loss of mitochondrial membrane potentials, which is known as one of the characteristics for uncouplers of oxidative phosphorylation, and also was caused by mefenamic acid and diclofenac. Incubation of hepatocytes with mefenamic acid, diclofenac, and diphenylamine diminished cellular ATP content, followed by leakage of lactose dehydrogenase from hepatocytes. Fructose, a low Km substrate for glycolysis, partially protected against the ATP depletion and hepatocyte injury induced by these compounds. Further addition of oligomycin, which blocks ATPase, pronounced the protection against cell injury. These results suggested that decreases in cellular ATP content, mainly caused by uncoupling of mitochondrial oxidative phosphorylation, were responsible for acute hepatocyte injury induced by diphenylamine and structurally related NSAIDs.


0022-3565/00/2923-0982$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Dou, S. Thompson-Jaeger, S. J. F. Laulederkind, J. W. Becker, J. Montgomery, E. Ruiz-Bustos, D. L. Hasty, L. R. Ballou, P. S. Eastman, B. Srichai, et al.
Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F49 - F60.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Salvatella, I. Rossi, J. C. Del Valle, Y. Gutierrez, C. Pereda, B. Samper, and J. E. Feliu
Inhibition of acid secretion by the nonsteroidal anti-inflammatory drugs diclofenac and piroxicam in isolated gastric glands: analysis of a multifocal mechanism
Am J Physiol Gastrointest Liver Physiol, May 1, 2004; 286(5): G711 - G721.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
N. O'connor, P.I. Dargan, and A.L. Jones
Hepatocellular damage from non-steroidal anti-inflammatory drugs
QJM, November 1, 2003; 96(11): 787 - 791.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. E. Mingatto, T. Rodrigues, A. A. Pigoso, S. A. Uyemura, C. Curti, and A. C. Santos
The Critical Role of Mitochondrial Energetic Impairment in the Toxicity of Nimesulide to Hepatocytes
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 601 - 607.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. Grosse-Siestrup, J. Pfeffer, V. Unger, S. Nagel, C. Witt, A. Fischer, and D. A. Groneberg
Isolated Hemoperfused Slaughterhouse Livers as a Valid Model to Study Hepatotoxicity
Toxicol Pathol, October 1, 2002; 30(6): 749 - 754.
[Abstract] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Mitochondrial Medicine - Molecular Pathology of Defective Oxidative Phosphorylation
Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 25 - 67.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.